News 10 Oct 2024 Nobel prize for chemistry awarded to Demis Hassabis and John Jumper for AlphaFold, an AI model used by DNDi for neglected diseases
Scientific articles 8 Oct 2024 Discovery of a series of macrocycles as potent inhibitors of Leishmania Infantum Journal of Medicinal Chemistry
Viewpoints 7 Oct 2024 On World Meningitis Day, too many people are dying of cryptococcal meningitis in Africa African Arguments
In the media 7 Oct 2024 New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine The Lancet Infectious Diseases
News 4 Oct 2024 DNDi 2024 Projects of the Year recognize contributions of DNDi teams and partners working to deliver medical innovations for people affected by leishmaniasis and sleeping sickness
Scientific articles 25 Sep 2024 The promise of health for all: a collaborative model to close treatment gaps for neglected diseases Clinical Pharmacology and Therapeutics
Scientific articles 18 Sep 2024 Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis Clinical and Translational Science
Scientific articles 17 Sep 2024 Challenges and advancements in the development of vaccines and therapies against Chagas disease The Lancet Microbe
Scientific articles 13 Sep 2024 Climate change and Trypanosoma cruzi transmission in North and central America The Lancet Microbe
Press releases 17 Jul 2024 Clinical trial in Eastern Africa finds a shorter, safer, and more effective treatment for PKDL, a stigmatizing skin disease
Press releases 1 Jul 2024 WHO recommends first all-oral treatment for acute sleeping sickness found in Eastern and Southern Africa
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
Press releases 8 Dec 2023 Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease
Press releases 5 Dec 2023 Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa
Press releases 3 Dec 2023 Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases
Press releases 23 Nov 2023 World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment
Press releases 16 Oct 2023 DNDi signs memorandum of understanding with Spanish Agency for International Development Cooperation
Press releases 11 Oct 2023 DNDi receives 2023 Princess of Asturias Award for International Cooperation